QU

Quantum Base Holdings PLC

IL

Overview

Corporate Details

ISIN(s):
GB00BTXYPJ53
LEI:
9845002F5A9EY5AM4B40
Country:
United Kingdom
Address:
N/A
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Quantum Base Holdings PLC is a quantum science company specializing in anti-counterfeiting and authentication technology. Its core product, Q-ID®, is a unique and uncopiable 'atomic-level fingerprint' that can be applied to products, packaging, and documents. The technology enables instant verification using any standard smartphone, providing a highly scalable and accessible solution for brand protection, supply chain security, and document verification. The company's solution is designed for low-cost integration with existing printing processes and is deployed through partnerships with global security organizations.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Quantum Base Holdings PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-28 08:00
Board/Management Information
Appointment of Non-Executive Director
English 17.0 KB

Automate Your Workflow. Get a real-time feed of all Quantum Base Holdings PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Quantum Base Holdings PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Circio Holding ASA Logo
Developing circular RNA medicines for gene and cell therapies for hard-to-treat diseases.
Norway CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a blood test for early lung cancer detection using a proprietary CIZ1B biomarker.
United Kingdom CIZ
Combigene AB Logo Sweden COMBI
Compugen Ltd. Logo
AI-driven discovery of novel antibody therapies for cancer immunotherapy.
Israel CGEN
Virgin Islands (British) N/A
Cte Group Spolka Akcyjna Logo
Provides B2B services, corporate events, and advanced composite materials R&D.
Poland LPS
Curasight A/S Logo
Developing a theranostics platform for precise diagnosis and targeted radiation therapy for cancer.
Denmark CURAS
Cyclezyme AB Logo
Develops enzymes to recycle PET plastic waste into new high-quality materials.
Sweden CYCLE
Cyxone AB Logo Sweden CYXO
DARWIN AG Logo
AI-powered biotech creating personalized health solutions from biological data for B2C & B2B.
Germany 7V0